Cas:301-08-6 LEAD(II) 2-ETHYLHEXANOATE manufacturer & supplier

Chemical Name:LEAD(II) 2-ETHYLHEXANOATE

CAS.NO:301-08-6

Synonyms:Lead(2+) bis(2-ethylhexanoate);EINECS 206-107-0;2-Ethylhexanoic acid lead(II) salt;LEAD(II) 2-ETHYLHEXANOATE;Lead bis(2-ethylhexanoate);MFCD00014003

Molecular Formula:C₁₆H₃₀O₄Pb

Molecular Weight:493.60700

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:228ºC at 760mmHg

Density:1.56

Index of Refraction:

PSA:80.26000

Exact Mass:494.19100

LogP:1.52460

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 2291

Packing Group:III

Contact us for information like Lead(2+) bis(2-ethylhexanoate) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00014003 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Ethylhexanoic acid lead(II) salt Use and application,LEAD(II) 2-ETHYLHEXANOATE technical grade,usp/ep/jp grade.

Related News: Also, the study did not compare people who had COVID-19 with those who did not, to see if such symptoms were higher than in the general population. The report did exclude patients with certain serious or chronic preexisting conditions like cancer, kidney disease, HIV, liver disease and stroke, to separate their previous health status from post-COVID symptoms. LEAD(II) 2-ETHYLHEXANOATE manufacturer The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful. LEAD(II) 2-ETHYLHEXANOATE supplier At the same time, due to the increase in production costs and environmental protection cost pressures in Europe and the United States, as well as the improvement of process technology, production quality, and registration and certification capabilities of China’s bulk drug manufacturers, bulk drug companies have accelerated their transfer to China, and the bulk drug industry in China has produced Scale continues to increase. LEAD(II) 2-ETHYLHEXANOATE vendor Also, the study did not compare people who had COVID-19 with those who did not, to see if such symptoms were higher than in the general population. The report did exclude patients with certain serious or chronic preexisting conditions like cancer, kidney disease, HIV, liver disease and stroke, to separate their previous health status from post-COVID symptoms. LEAD(II) 2-ETHYLHEXANOATE factory The number of Americans living with Alzheimer’s is expected to more than double to around 13 million by 2050, according to the Alzheimer’s Association.